Despite the growing evidence connecting chronic inflammation to breast cancer progression [43, 44], to our knowledge this is the first study investigating the impact of tumor Sdc-1 silencing on polarization of T helper cells towards Th1, Th2, Th17, and Treg subsets isolated from non-IBC and IBC breast cancer patients. Here, SDC1 is linked to breast cancer.